TY - JOUR
T1 - Regulatory and ethical issues with dietary supplements
AU - Harris, I. M.
PY - 2000
Y1 - 2000
N2 - Dietary supplements are commonly used, and many are effective or hold promise for treating various conditions. However, they do not require Food and Drug Administration (FDA) approval. Impurities and adulterants have been found in the products, mostly due to the lack of requirements for good manufacturing practices. In addition, as no standardization is required, the active ingredient may be absent or highly variable among manufacturers. The FDA published its 10-year plan for dietary supplements that addresses safety, labeling, boundaries, enforcement, research, and outreach. This endeavor, if put into place, will be instrumental in providing consumers with more confidence in the safety, composition, and labeling of dietary supplements.
AB - Dietary supplements are commonly used, and many are effective or hold promise for treating various conditions. However, they do not require Food and Drug Administration (FDA) approval. Impurities and adulterants have been found in the products, mostly due to the lack of requirements for good manufacturing practices. In addition, as no standardization is required, the active ingredient may be absent or highly variable among manufacturers. The FDA published its 10-year plan for dietary supplements that addresses safety, labeling, boundaries, enforcement, research, and outreach. This endeavor, if put into place, will be instrumental in providing consumers with more confidence in the safety, composition, and labeling of dietary supplements.
UR - http://www.scopus.com/inward/record.url?scp=0033766195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033766195&partnerID=8YFLogxK
U2 - 10.1592/phco.20.17.1295.34896
DO - 10.1592/phco.20.17.1295.34896
M3 - Review article
C2 - 11079277
AN - SCOPUS:0033766195
SN - 0277-0008
VL - 20
SP - 1295
EP - 1302
JO - Pharmacotherapy
JF - Pharmacotherapy
IS - 11 I
ER -